50 Participants Needed

TDCS + Phonomotor Therapy for Aphasia

Recruiting at 1 trial location
OB
Overseen ByOlga Boukrina, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Kessler Foundation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Transcranial Direct Current Stimulation (tDCS) combined with Phonomotor Therapy for Aphasia?

Research shows that transcranial direct current stimulation (tDCS) can improve language skills in people with aphasia (language impairment) after a stroke. For example, one study found that tDCS significantly improved naming accuracy in patients, suggesting it can be a helpful addition to speech therapy.12345

Is Transcranial Direct Current Stimulation (tDCS) safe for humans?

Research shows that tDCS is generally safe for humans, with no serious adverse events reported in studies involving people with aphasia after stroke. It is a noninvasive brain stimulation method that can be safely combined with language therapy over extended periods.46789

How does the TDCS + Phonomotor Therapy treatment for aphasia differ from other treatments?

TDCS + Phonomotor Therapy is unique because it combines transcranial direct current stimulation (tDCS), which uses a mild electrical current to stimulate the brain, with phonomotor therapy, a type of speech therapy focused on improving language skills. This combination aims to enhance the effects of speech therapy by potentially increasing brain activity and language recovery, offering a novel approach compared to standard speech therapy alone.123610

What is the purpose of this trial?

This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life.The study aims to test a new approach to reading rehabilitation by combining Phono-Motor Treatment (PMT), a language therapy adapted to improve reading, with transcranial direct current stimulation (tDCS), a safe and painless brain stimulation technique. tDCS delivers a mild electrical current to the brain, which may enhance learning. This study will assess whether adding tDCS to PMT improves reading therapy outcomes.

Eligibility Criteria

This trial is for individuals who have aphasia, a language disorder often caused by stroke. Participants should struggle with reading due to their condition and are looking to improve their abilities through therapy.

Inclusion Criteria

I had a stroke in the left side of my brain over 6 months ago.
Deficits in reading aloud
I have been diagnosed with aphasia.

Exclusion Criteria

Contraindications of tDCS or MRI: Skin condition affecting the skull (e.g., psoriasis) or open wounds at the stimulation site, Presence of metallic implants (e.g., cardiac stimulators or pacemakers, cochlear implants), History of ongoing/unmanaged seizures, Pregnancy, Claustrophobia, Inability to lie flat on the back
I do not have severe speech issues or cognitive problems that prevent me from participating.
I do not have brain disorders like Alzheimer's, Dementia, or Parkinson's.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive different combinations of PMT and tDCS over six weeks, with assessments before, during, and after treatment

6 weeks
Multiple visits at two sites: Kessler Foundation and MCW

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Transcranial Direct Current Stimulation
Trial Overview The study tests the effectiveness of combining Phono-Motor Treatment (PMT), a specialized language therapy for reading improvement, with transcranial direct current stimulation (tDCS), which uses mild electrical currents to potentially enhance learning.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Early tDCSExperimental Treatment1 Intervention
This group will undergo Active tDCS + PMT for weeks 1-3 and Sham tDCS + PMT for weeks 4-6.
Group II: Interleaved tDCSActive Control1 Intervention
This group will receive PMT + Active/Sham tDCS on alternate days for 6 weeks.
Group III: Late tDCSPlacebo Group1 Intervention
This group will undergo Sham tDCS + PMT for weeks 1-3 and Active tDCS + PMT for weeks 4-6.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kessler Foundation

Lead Sponsor

Trials
190
Recruited
11,300+

Medical College of Wisconsin

Collaborator

Trials
645
Recruited
1,180,000+

Findings from Research

In a study of 37 stroke patients, speech therapy combined with transcranial direct current stimulation (tDCS) significantly improved language function, with an average increase in aphasia quotient (AQ%) of 14.94% after treatment.
Patients with less severe, fluent types of aphasia who started treatment within 30 days of their stroke showed the best responses, and those with hemorrhagic strokes had a higher likelihood of improvement compared to those with infarctions.
The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients.Jung, IY., Lim, JY., Kang, EK., et al.[2021]
In a study involving 11 chronic stroke patients with aphasia, dual transcranial direct current stimulation (tDCS) showed a significant improvement in naming response times compared to baseline, suggesting enhanced efficacy over single tDCS.
Both single and dual tDCS improved the number of correct responses in naming tasks, but dual tDCS, which targeted both the left and right inferior frontal gyri, may offer greater benefits for language recovery in stroke patients.
Effects of dual transcranial direct current stimulation for aphasia in chronic stroke patients.Lee, SY., Cheon, HJ., Yoon, KJ., et al.[2021]
In a study of 14 individuals with post-stroke aphasia, transcranial direct current stimulation (tDCS) showed significant improvement in naming tasks, particularly in the Boston test, indicating its potential efficacy in language rehabilitation.
The study suggests that the placement of electrodes over specific brain areas can enhance recovery in patients with anomic and Broca's aphasia, highlighting the importance of considering language strategies in treatment assessments.
Transcranial direct current stimulation: a study on naming performance in aphasic individuals.Silva, FRD., Mac-Kay, APMG., Chao, JC., et al.[2022]

References

The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients. [2021]
Effects of dual transcranial direct current stimulation for aphasia in chronic stroke patients. [2021]
Transcranial direct current stimulation: a study on naming performance in aphasic individuals. [2022]
Transcranial Direct-Current Stimulation in Subacute Aphasia: A Randomized Controlled Trial. [2023]
Improved naming after transcranial direct current stimulation in aphasia. [2022]
Extended fMRI-Guided Anodal and Cathodal Transcranial Direct Current Stimulation Targeting Perilesional Areas in Post-Stroke Aphasia: A Pilot Randomized Clinical Trial. [2021]
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial. [2021]
Clinical Feasibility of Combining Transcranial Direct Current Stimulation with Standard Aphasia Therapy. [2022]
Transcranial direct current stimulation (tDCS) for improving aphasia after stroke: a systematic review with network meta-analysis of randomized controlled trials. [2020]
Case report: the effects of cerebellar tDCS in bilingual post-stroke aphasia. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security